Streamex Corporation (STEX) - Pangali EV/EBITDA

Streamex Corp (STEX) is a biotechnology holding company developing BioSig cardiology systems and implementing PURE EP equipment, where high profitability is driven by AI modules for ECG. This price chart shows a value of 0.00. Streamex Corp (STEX) is reorganizing its assets to promote niche med-tech through scientific alliances, while financial control over tech stakes is maintained via algorithmic investment portfolio management.

The EV/EBITDA multiple compares the total enterprise value, including net debt, to its operating income before taxes, depreciation, and amortization. The current EV/EBITDA multiple of 0.00 indicates how many years of earnings would be required to acquire the company. This metric measures cash flow generation efficiency relative to the market price. For Streamex Corp (STEX), this indicator reflects the market's wait-and-see approach during the holding's period of strategic transformation.